Prostate Cancer News on BioPortfolio

MagForce MF6 Scale Update 2017 lays foundation for 2018 progress

Edison Investment Research Pharmaceutical & healthcare MagForce MagForce continues to execute its twopronged strategy. With €35m now available in financing from the European Investment Bank EIB MagForce can roll out its Nanotherm devices out...

Increased Colorectal Cancer Risk After Advanced Adenoma Detection

The risk of developing colorectal cancer CRC is increased in individuals with an advanced adenoma at diagnostic colonoscopy prompted by CRC screening according to findings from the Prostate Lung Colorectal and Ovarian PLCO Cancer trial. Reuters Health In...

MagForce MF6 2017 lays foundation for 2018 progress

Edison Investment Research Pharmaceutical & healthcare MagForce MagForce continues to execute its twopronged strategy. With €35m now available in financing from the EIB MagForce can now roll out its Nanotherm devices outside of Germany for t...

Could Mother Natures clinical trial help prevent more cancers

Science blog One of the best ways to save lives from cancer is preventing tumours from developing in the first place.But like any new treatment ways to prevent cancer also have to be tested in clinical trials to make sure they work. Even something as widel...

Jiangsu Ambition Inlicenses Prostate Treatment from Sweden's Lidds

Jiangsu Ambition Medical has inlicensed China rights to a prostate treatment that is delivered via an injected depot system which administers the drug directly to the tumor for up to six months. Sweden's Lidds AB developed Liproca® Depot and is cur...

Pages